Here’s a roundup of the latest coronavirus-related news.
The COVID-19 vaccination effort is well underway in the US, with over 115.73 million administered doses and 12.3% of the population fully vaccinated against the virus as of March 18.
This week, several European countries have temporarily suspended the use of AstraZeneca’s COVID-19 vaccine, and the Centers for Medicare and Medicaid Services (CMS) is increasing the Medicare payment for administering COVID-19 vaccines.
Here’s a roundup of the latest coronavirus-related news:
The preliminary results of a recent survey showed that independent community pharmacies may be better positioned to implement COVID-19 point-of-care (POC) than chains, although strategies across the board could be improved.
Often referred to as “long COVID” patients or “long-haulers,” these patients continue to experience symptoms of illness far past the acute phase of this viral disease.
Patrick Bordnick, dean of the Tulane University School of Social Work, discusses the resources that the university has been offering for health care professionals and anyone else who is interested in prioritizing self-care amid the pandemic.
Several European countries have temporarily suspended AstraZeneca’s vaccine for COVID-19 due to reports of patients having severe blood clots, though the pharmaceutical company pointed to a lack of evidence for the claim.
Many individuals have been asking if they can take things at home, such as vitamins and OTC medications, to decrease their risk of contracting the virus or to self-treat themselves.
CMS is increasing the Medicare payment amount for administering the COVID-19 vaccine, according to a statement from CMS.
An update on COVID-19 advocacy activity and regulations affecting your pharmacy practice.